Evidence map›Paper›PMID 24634495›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

B cell differentiation is associated with reprogramming the CCCTC binding factor-dependent chromatin architecture of the murine MHC class II locus.

Parimal Majumder, Christopher D Scharer, Nancy M Choi, Jeremy M Boss

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. H3K27me3 Demethylase UTX Restrains Plasma Cell Formation.Journal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  4. Article
  5. Epigenetic gene regulation in plasma cells.Immunological reviews · 2021
    Review
  6. The Murine MHC Class II Super EnhancerJournal of immunology (Baltimore, Md. : 1950) · 2021
    Article
  7. Review
  8. Article
  9. Epigenetic Priming in Immunodeficiencies.Frontiers in cell and developmental biology · 2019
    Review
  10. Article
  11. Article
  12. Developing in 3D: the role of CTCF in cell differentiation.Development (Cambridge, England) · 2018
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Parimal MajumderDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322.
Christopher D Scharer
Nancy M Choi
Jeremy M Boss
Emory University · US

Funding

Regulation of MHC Class II GenesR01GM047310 · NIGMS · EMORY UNIVERSITY · PI BOSS, JEREMY M. · 1993 to 2015
$4.6M
GENETICS &FUNCTIONS OF HSV1 GK IN VIRUS ENTRY &EGRESSR01AI043000 · NIAID · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI KOUSOULAS, KONSTANTIN G · 1999 to 2009
$2.4M
NIAID NIH HHS AI43000NIAID NIH HHS R01 AI043000NIGMS NIH HHS GM47310NIGMS NIH HHS R01 GM047310
6 · The paper itself

Abstract

The transcriptional insulator CCCTC binding factor (CTCF) was shown previously to be critical for human MHC class II (MHC-II) gene expression. Whether the mechanisms used by CTCF in humans were similar to that of the mouse and whether the three-dimensional chromatin architecture created was specific to B cells were not defined. Genome-wide CTCF occupancy was defined for murine B cells and LPS-derived plasmablasts by chromatin immunoprecipitation sequencing. Fifteen CTCF sites within the murine MHC-II locus were associated with high CTCF binding in B cells. Only one-third of these sites displayed significant CTCF occupancy in plasmablasts. CTCF was required for maximal MHC-II gene expression in mouse B cells. In B cells, a subset of the CTCF regions interacted with each other, creating a three-dimensional architecture for the locus. Additional interactions occurred between MHC-II promoters and the CTCF sites. In contrast, a novel configuration occurred in plasma cells, which do not express MHC-II genes. Ectopic CIITA expression in plasma cells to induce MHC-II expression resulted in high levels of MHC-II proteins, but did not alter the plasma cell architecture completely. These data suggest that reorganizing the three-dimensional chromatin architecture is an epigenetic mechanism that accompanies the silencing of MHC-II genes as part of the cell fate commitment of plasma cells.

Indexed as

Cell DifferentiationGenetic LociAnimalsBinding SitesB-LymphocytesCCCTC-Binding FactorCell LineChromatinChromatin ImmunoprecipitationGene Expression RegulationH-2 AntigensMiceNucleotide MotifsPlasma CellsPosition-Specific Scoring MatricesPromoter Regions, GeneticCCCTC-Binding FactorChromatinCTCF protein, humanCtcf protein, mouseH-2 AntigensRepressor Proteins

Identifiers

PMID24634495
PMCPMC3982198
OpenAlexW2136821314

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.